Call for Letters of Intent for studies that will improve outcomes for recurrent osteosarcoma patients

The Osteosarcoma Institute (OSI) was established to develop a comprehensive strategy that will lead to major improvement in the life expectancy of patients with relapsed and metastatic osteosarcoma.

To further this goal, the OSI is seeking Letters of Intent (LOI) for grant proposals to conduct clinical, correlative, and translational studies.

Funding: $250,000 per year 

Duration: 2 years

Research Authority due dates: 8.11.222

LOI  (required) due date: 15.11.222

Full proposal due date: 14.4.23